-
China Aims To Build World’s First Exascale Supercomputer Prototype By End Of 2017
The Verge | Building supercomputers is a digital arms race, and China is moving quickly to solidify its lead. This year the government has set its sights on completing the world's first prototype exascale computer; a machine capable of making a billion calculations per second.
Jan 19, 2017
-
Obama Administration Decides Consent Of Patients Not Needed To Study Their Blood DNA
NPR.org | In its update of ethics rules aimed at protecting patients, the Obama administration decided against a provision that scientists said would hinder research. Consumer advocates aren't happy.
Jan 18, 2017
-
AI Software Learns to Make AI Software
MIT Technology Review | Google and others think software that learns to learn could take over some work done by AI experts.
Jan 18, 2017
-
Where The Money Is: 2016 Edition
ENDPOINTS NEWS | Thomson Reuters dug up investment numbers for all of the top 100 VCs investing in biotech, and Endpoints News ranked them. Flagship, Third Rock, New Enterprise Associates, and Arch Venture are the top four, and many of the top four players remain focused on early stage investment.
Jan 18, 2017
-
Novogene Purchases 10 PacBio Sequel Systems
Bio-IT World Brief | Novogene today announced its intention to purchase 10 Sequel Systems for whole genome sequencing, Iso-Seq annotation and targeted sequencing services from Pacific Biosciences.
Jan 16, 2017
-
The Stem-Cell Revolution Is Coming — Slowly
The New York Times | Where are the miracle treatments we were promised? A Nobel Prize-winning scientist explains.
Jan 16, 2017
-
Biotech IPO Master Is Still Setting Up New Biotechs And Hatching More Deals
ENDPOINTS NEWS | Vivek Ramaswamy blindsided the biotech industry with a record-setting IPO for the mystery biotech Axovant. The one-time hedge fund maestro turned drug entrepreneur has set up three more companies and taken one of them public at near supersonic speed, all while busily in-licensing drugs from a growing list of suppliers.
Jan 13, 2017
-
JP Morgan News Round Up
Bio-IT World Brief | The JP Morgan Healthcare Conference was held this week in San Francisco, kicking off 2017 with news and deals and product announcements. Many presentations were webcast. Here are some of the highlights and news bits we’ve collected over the past three days.
Jan 12, 2017
-
Illumina Launches NovaSeq Sequencers, Aiming To Replace 1900 Sequencers
Bio-IT World Speaking at the J.P. Morgan Healthcare Conference this afternoon, Francis deSouza, President and CEO of Illumina, unveiled the NovaSeq series, a new and scalable sequencing architecture, comprised of two instruments: the NovaSeq 5000 and NovaSeq 6000.
Jan 9, 2017
-
Mysterious $5 Billion Biotech Firm Moderna Lays Out Drug Pipeline
Forbes | What drugs is Moderna developing? It finally gives some details at JP Morgan.
Jan 9, 2017
-
PatientsLikeMe Joins Wang's iCarbonX Digital Life Alliance Cornerstone
Diagnostics World | Last week PatientsLikeMe announced a partnership and investment from iCarbonX that positions PatientsLikeMe as the cornerstone of Jun Wang's iCarbonX Digital Life Alliance, which aims to digitize and analyze all aspects of life.
Jan 9, 2017
-
Will Our Government’s Multi-Billion-Dollar Investment In Genome Science Pay Off?
Pacific Standard | Though the medical benefits of genome science have been marginal thus far, the government's multi-billion-dollar investment could pay off with the right policy adjustments.
Jan 9, 2017
-
Interference: A CRISPR Patent Dispute Roadmap
Bio-IT World | An epic CRISPR litigation battle between a host of universities has erupted involving CRISPR/Cas9, which can have major implications for the gene-editing technology community.
Jan 9, 2017
-
Guide RNA Synthesis Firm Synthego Gets Investment, Vote Of Doudna Confidence
Bio-IT World This week Synthego, a leading provider of genome engineering solutions, announced a $41 million Series B financing, bringing the company’s total fundraising to $50 million. The latest round includes investment from several venture firms, as well as direct, individual investments from Jennifer Doudna and Jamie Cate.
Jan 6, 2017
-
BioTeam’s Berman Charts 2017 HPC Trends in Life Sciences
HPCwire | Twenty years ago high performance computing was nearly absent from life sciences. Today it's used throughout life sciences and biomedical research. Genomics and the data deluge from modern lab instruments are the main drivers, but so is the longer-term desire to perform predictive simulation in support of Precision Medicine (PM).
Jan 6, 2017
-
Boston Biotech Pieris Nabs Cancer Deal With French Powerhouse Servier
Bio-IT World News Brief | Pieris and Servier today announced a broad collaboration in immuno-oncology. Under the collaboration, Pieris and Servier will initially pursue five bispecific therapeutic programs.
Jan 5, 2017
-
WuXi NextCODE Chosen To Support Singapore Precision Medicine Pilot
Bio-IT World | The National Heart Centre of Singapore (NHCS) has chosen WuXi NextCODE to support its 18-month proof-of-concept precision medicine project, focusing on cardiovascular disease.
Jan 4, 2017
-
Edico Genome’s Deal with Dell EMC Fits Partnership Strategy
Xconomy | San Diego's Edico Genome is now in its fourth year as a startup, and well into the hard slog of striking partnership deals, generating revenue, and building a business.
Jan 4, 2017
-
AstraZeneca CIO Makes IT Twice As Good At Half The Cost - Here Is How
Forbes | Dave Smoley has led a remarkable transformation of the information technology function at AstraZeneca during his nearly four years as CIO. He has codified the methods used to double IT's value at half the cost in ways that others can follow, as well.
Jan 3, 2017
-
Gene Therapy To Prevent Inherited Diseases May Cause Other Ills
NPR.org | In 2016, scientists combined the genes of three people in an effort to make a baby free of an inherited disease. But the process doesn't wipe out all faulty mitochondria, and could pose new risks.
Jan 3, 2017